论文部分内容阅读
目的研究稳心颗粒联合美托洛尔治疗高血压心脏病室早搏的疗效。方法选取2013年7月~2014年7月在我院接受治疗的高血压心脏病室性早搏患者100例为研究对象,将其分为对照组和实验组,各50例。对照组给予美托洛尔进行治疗,实验组给予稳心颗粒联合美托洛尔进行治疗,分析和对比两组疗效。结果经过一年治疗,对照组与实验组的总有效率分别为68.00%和92.00%,不良反应发生率分别为22.00%和6.00%,差异有统计学意义(P<0.05)。结论稳心颗粒联合美托洛尔治疗高血压心脏病室性早搏疗效显著,且安全性较高,值得推广应用。
Objective To study the curative effect of Wenxin granule combined with metoprolol in the treatment of premature beats of hypertensive heart disease. Methods A total of 100 patients with premature ventricular hypertrophy treated in our hospital from July 2013 to July 2014 were selected as study subjects and divided into control group and experimental group with 50 cases in each group. The control group was given metoprolol for treatment, and the experimental group was given Wenxin granules combined with metoprolol for treatment. The curative effect was analyzed and compared between the two groups. Results After a year of treatment, the total effective rate was 68.00% in the control group and 92.00% in the experimental group. The incidence of adverse reactions were 22.00% and 6.00% respectively, with significant difference (P <0.05). Conclusion Wenxin granule combined with Metoprolol has significant curative effect on ventricular premature beats of hypertensive heart disease and its safety is high and it is worth popularizing and applying.